Decay-accelerating factor 1 deficiency exacerbates Trypanosoma cruzi-induced murine chronic myositis.

INTRODUCTION: Murine infection with Trypanosoma cruzi (Tc) has been used to study the role of T-cells in the pathogenesis of human inflammatory idiopathic myositis. Absence of decay-accelerating factor 1 (Daf1) has been shown to enhance murine T-cell responses and autoimmunity. METHODS: To determine whether Daf1 deficiency can exacerbate Tc-induced myositis, C57BL/6 DAF(+/+) and DAF(-/-) mice were inoculated with 5 × 10(4) trypomastigotes, and their morbidity, parasitemia, parasite burden, histopathology, and T-cell expansion were studied in the acute and chronic stages. RESULTS: DAF(-/-) mice had lower parasitemia and parasite burden but higher morbidity, muscle histopathology, and increased number of CD44(+) (activated/memory phenotype) splenic CD4(+) and CD8(+) T-cells. CONCLUSIONS: An enhanced CD8(+) T-cell immune-specific response may explain the lower parasitemia and parasite burden levels and the increase in histopathological lesions. We propose that Tc-inoculated DAF(-/-) mice are a useful model to study T-cell mediated immunity in skeletal muscle tissues.

Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.

C3H/HeN male mice were infected with a lethal population of Trypanosoma cruzi and treated with benznidazole (Bz). Parasitemia, body weight and survival rate were registered during the therapy with significant improvement for T. cruzi-infected Bz-treated animals. Besides, flow cytometry resulted a useful method to discriminate between cured animals from those not cured by monitoring IgG(1) bound to live trypomastigotes levels. At the end of Bz therapy, the LT splenocyte compartment was studied for activation/memory cell surface markers (CD(69)(+) and CD(44)(+)). Cytofluorometric analysis showed that T. cruzi-infected untreated mice increased their activated LT numbers and this effect was completely abolished only in cured mice at the end of Bz administration. The same behavior was observed for the memory LT subpopulation correlating to an effector memory (CD(62L)(-)) displayed by T. cruzi infection. Bz treatment was able to modulate the immunological response by reducing the deleterious effect of the acute phase in all T. cruzi-infected mice.

Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi.

BACKGROUND: Cells of monocyte/macrophage lineage are one of the major targets of HIV-1 infection and serve as reservoirs for viral persistence in vivo. These cells are also the target of the protozoa Trypanosoma cruzi, the causative agent of Chagas disease, being one of the most important endemic protozoonoses in Latin America. It has been demonstrated in vitro that co-infection with other pathogens can modulate HIV replication. However, no studies at cellular level have suggested an interaction between T. cruzi and HIV-1 to date. METHODOLOGY/PRINCIPAL FINDINGS: By using a fully replicative wild-type virus, our study showed that T. cruzi inhibits HIV-1 antigen production by nearly 100% (p<0.001) in monocyte-derived macrophages (MDM). In different infection schemes with luciferase-reporter VSV-G or BaL pseudotyped HIV-1 and trypomastigotes, T. cruzi induced a significant reduction of luciferase level for both pseudotypes in all the infection schemes (p<0.001), T. cruzi-HIV (>99%) being stronger than HIV-T. cruzi (approximately 90% for BaL and approximately 85% for VSV-G) infection. In MDM with established HIV-1 infection, T. cruzi significantly inhibited luciferate activity (p<0.01). By quantifying R-U5 and U5-gag transcripts by real time PCR, our study showed the expression of both transcripts significantly diminished in the presence of trypomastigotes (p<0.05). Thus, T. cruzi inhibits viral post-integration steps, early post-entry steps and entry into MDM. Trypomastigotes also caused a approximately 60-70% decrease of surface CCR5 expression on MDM. Multiplication of T. cruzi inside the MDM does not seem to be required for inhibiting HIV-1 replication since soluble factors secreted by trypomastigotes have shown similar effects. Moreover, the major parasite antigen cruzipain, which is secreted by the trypomastigote form, was able to inhibit viral production in MDM over 90% (p<0.01). CONCLUSIONS/SIGNIFICANCE: Our study showed that T. cruzi inhibits HIV-1 replication at several replication stages in macrophages, a major cell target for both pathogens.

Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner.

A striking feature of Chagas' disease is the diversity of clinical presentations. Such variability may be due to the heterogeneity among Trypanosoma cruzi isolates or to the host immune response. Employing two strains which differ in their virulence, we investigated the effect of in vivo infection on professional antigen-presenting cells (APC). Acute infection with the virulent RA strain downregulated the expression of major histocompatibility complex (MHC) class II on splenic dendritic cells (DC) and inhibited its induction on peritoneal macrophages and splenic B cells. It also impaired the ability of DC to prime allogeneic T cells and to form homotypic clusters, suggesting a low maturation state of these cells. In contrast, the low-virulence K98 strain maintained the expression of MHC class II on DC or stimulated it on peritoneal macrophages and B cells and preserved DC's T-cell priming capacity and homotypic clustering. DC from RA-infected mice elicited a lower activation of T. cruzi-specific T-cell proliferation than those from K98-infected mice. APC from RA-infected mice that reached the chronic phase of infection restored MHC class II levels to those found in K98-infected mice and upregulated costimulatory molecules expression, suggesting that the immunosuppression caused by this strain is only transient. Taken together, the results indicate that in vivo infection with T. cruzi modulates APC functionality and that this is accomplished in a strain-dependent manner.

Host selenium deficiency increases the severity of chronic inflammatory myopathy in Trypanosoma cruzi-inoculated mice.

Weanling C3H/HeN mice were fed either a torula yeast-based diet deficient in selenium (Se) or the same diet supplemented with 0.2 ppm Se as sodium selenite. After 4 wk of feeding, the mice were inoculated intraperitoneally with the CA-I strain (clone K98) of Trypanosoma cruzi (TC). Before inoculation, mean serum Se levels were 430 versus 61 ng/ml in adequate and deficient mice, respectively. During the ascending phase of parasitemia, the Se-deficient mice exhibited significantly higher levels of parasites at 22-34 days postinfection (PI). However, no difference was found in the subsequent descending phase. As judged by visual examination at 2-mo-PI, some Se-deficient infected mice presented clinical signs of motor dysfunction. At 3-mo-PI, the end of the observation period, this chronic disease developed into a hind limb flaccid paralysis affecting 5 of 8 infected deficient mice. No signs of paralysis were seen in noninfected mice fed either diet or in infected mice fed the Se-adequate diet. At the histological level, both Se-adequate and Se-deficient infected mice showed mild myocarditis and moderate to severe myositis, with increasing intensity from 1- to 3-mo-PI in both groups. However, the severity of myositis was always more intense in the Se-deficient mice so that prominent areas of skeletal muscle replaced by fibrotic tissue were frequently observed. Thus, it can be concluded that Se deficiency in the murine host increases the severity of TC-induced myositis.

Patología por Trypanosoma cruzy. Cepa dependiente? / Is Trypanosoma cruzy pathology strain dependent?

En la actualidad existe consenso en el papel que las características de la población de Trypanosoma cruzi tienen en la patogésesis de las distintas formas clínicas de la enfermedad de Chagas. En nuestro laboratorio, estudiamos en el modelo murino las consecuencias de la infección con dos poblaciones de características biológicas polares: RA y CA-I. Demostramos que el daño neuromuscular es, en parte, mediato por diferentes subpoblaciones de linfocitos T. Además, observamos que el fenotipo celular responsable de la patologia y los distintos blancos tisulares dependen de la población parasitaria. A pesar de no haber observado diferencias en la reactividad jugaría un papel adicional en el desarrollo de la patología neuromuscular: sueros de ratones infectados con RA, pero no con CA-I, desencadenaron alteraciones en el potencial de acción nerviosa. También hemos detectado, en el modelo murino, una disminución en la fertilidad de las hembras infectadas con CA-I/K-98, mientras las hembras infectadas con RA se comportaron igual a los controles. Sin embargo, sólo pudo comprobarse pasaje transplacentario de T. cruzi en la cepa RA. Las diferencias encontradas en la fertilidad, en la sobrevida de las crías nacidas de madres infectadas, así como en el número de resorciones fetales detectadas con la cepa miotrópica, podrían atribuirse a la respuesta inflamatoria hallada en el útero de estas hembras, ya que no se observaron alteraciones en el estro de ambos grupos infectados con respecto a los controles.

Patología por Trypanosoma cruzy. Cepa dependiente? / Is Trypanosoma cruzy pathology strain dependent?

En la actualidad existe consenso en el papel que las características de la población de Trypanosoma cruzi tienen en la patogésesis de las distintas formas clínicas de la enfermedad de Chagas. En nuestro laboratorio, estudiamos en el modelo murino las consecuencias de la infección con dos poblaciones de características biológicas polares: RA y CA-I. Demostramos que el daño neuromuscular es, en parte, mediato por diferentes subpoblaciones de linfocitos T. Además, observamos que el fenotipo celular responsable de la patologia y los distintos blancos tisulares dependen de la población parasitaria. A pesar de no haber observado diferencias en la reactividad jugaría un papel adicional en el desarrollo de la patología neuromuscular: sueros de ratones infectados con RA, pero no con CA-I, desencadenaron alteraciones en el potencial de acción nerviosa. También hemos detectado, en el modelo murino, una disminución en la fertilidad de las hembras infectadas con CA-I/K-98, mientras las hembras infectadas con RA se comportaron igual a los controles. Sin embargo, sólo pudo comprobarse pasaje transplacentario de T. cruzi en la cepa RA. Las diferencias encontradas en la fertilidad, en la sobrevida de las crías nacidas de madres infectadas, así como en el número de resorciones fetales detectadas con la cepa miotrópica, podrían atribuirse a la respuesta inflamatoria hallada en el útero de estas hembras, ya que no se observaron alteraciones en el estro de ambos grupos infectados con respecto a los controles. (AU)